Lieberman 2001.
Trial name or title | Risperidone and clozapine in chronic schizophrenia. |
Methods | |
Participants | People severely ill with treatment resistant schizophrenia. |
Interventions | 1. Risperidone: 6 mg/day. 2. Risperidone: 16 mg/day. 3. Haloperidol. 4. Clozapine. |
Outcomes | Global state: CGI. Mental state: PANSS. Behaviour: NOSIE, Overt Aggression Scale. Social improvement: Quality of Life Interview. Cognitive effects. Adverse effects: ESRS. |
Starting date | |
Contact information | Sites of study: Bronx Psychiatric Centre (J Lieberman. Rockland Psychiatric Center, Manhattan Psychiatric Center (J Volavka) |
Notes | Allocation: random. Blindness: double. Duration: 12 weeks. |